The research for the urinary RANTES・MCP-1 as the urine tumor markers for bladder cancer

点击翻译按钮获取中文摘要

We measured the urinary cytokines using ELISA, and found that mean urinary RANTES level were significantly higher than that of healthy control. Immunohistologically, the expression of CCR5, which is main receptor of RANTES, was found in primary bladder tumors. There was a statistically significant association between increased CCR5 expression in tumors and tumor stage or tumor grade. The high grade or high stage tumors had significantly higher expression levels of CCR5.Our results suggest that the high level of urine RANTES may be a candidate novel marker of the presence of bladder cancer. Furthermore, the increased CCR5 expression in the cytoplasm of bladder cancer cells may be associated with aggressive type of bladder cancer and be a marker for disease progression.